The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα

Published:2015-05-18 Issue:12 Volume:29 Page:2442-2445
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Vargas Romero P,Cialfi S,Palermo R,De Blasio C,Checquolo S,Bellavia D,Chiaretti S,Foà R,Amadori A,Gulino A,Zardo G,Talora C,Screpanti I

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2015117.pdf

Reference15 articles.

1. Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.

2. Giambra V, Jenkins CR, Wang H, Lam SH, Shevchuk OO, Nemirovsky O et al. NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-theta and reactive oxygen species. Nat Med 2012; 18: 1693–1698.

3. Bousquet M, Harris MH, Zhou B, Lodish HF . MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci USA 2010; 107: 21558–21563.

4. Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S . MiR-125 in normal and malignant hematopoiesis. Leukemia 2012; 26: 2011–2018.

5. Sun YM, Lin KY, Chen YQ . Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol 2013; 6: 6.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic RNA Therapeutics in Cancer;Journal of Pharmacology and Experimental Therapeutics;2023-05-15

2. Discrete single-cell microRNA analysis for phenotyping the heterogeneity of acute myeloid leukemia;Biomaterials;2022-12

3. Extracellular Vesicles in Haematological Disorders: A Friend or a Foe?;International Journal of Molecular Sciences;2022-09-04

4. Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival;Biomedicine & Pharmacotherapy;2022-06

5. Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?;International Journal of Cancer;2021-12-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3